Clinical Trial

Clinical Study of HRS-2129 for Acute Gouty Arthritis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.
Trial Details
NCT Number NCT07706777
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Acute Gouty Arthritis
Enrollment 90 participants
Start Date 2026-07
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-16